Axsome Therapeutics Statistics
Total Valuation
AXSM has a market cap or net worth of $3.40 billion. The enterprise value is $3.20 billion.
| Market Cap | 3.40B |
| Enterprise Value | 3.20B |
Important Dates
The next confirmed earnings date is Monday, May 6, 2024, before market open.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AXSM has 47.37 million shares outstanding. The number of shares has increased by 11.73% in one year.
| Shares Outstanding | 47.37M |
| Shares Change (YoY) | +11.73% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 17.12% |
| Owned by Institutions (%) | 83.57% |
| Float | 34.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.55 |
| Forward PS | 8.67 |
| PB Ratio | 17.79 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.63, with a Debt / Equity ratio of 0.98.
| Current Ratio | 3.63 |
| Quick Ratio | 3.46 |
| Debt / Equity | 0.98 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -35.93 |
Financial Efficiency
Return on equity (ROE) is -112.40% and return on invested capital (ROIC) is -61.44%.
| Return on Equity (ROE) | -112.40% |
| Return on Assets (ROA) | -43.70% |
| Return on Capital (ROIC) | -61.44% |
| Revenue Per Employee | $496,514 |
| Profits Per Employee | -$438,969 |
| Employee Count | 545 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.68 |
Taxes
In the past 12 months, AXSM has paid $960,000 in taxes.
| Income Tax | 960,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.41% in the last 52 weeks. The beta is 1.10, so AXSM's price volatility has been similar to the market average.
| Beta (1Y) | 1.10 |
| 52-Week Price Change | +0.41% |
| 50-Day Moving Average | 76.00 |
| 200-Day Moving Average | 74.79 |
| Relative Strength Index (RSI) | 47.36 |
| Average Volume (30 Days) | 725,532 |
Short Selling Information
The latest short interest is 7.75 million, so 16.36% of the outstanding shares have been sold short.
| Short Interest | 7.75M |
| Short Previous Month | 7.65M |
| Short % of Shares Out | 16.36% |
| Short % of Float | 22.22% |
| Short Ratio (days to cover) | 11.26 |
Income Statement
In the last 12 months, AXSM had revenue of $270.60 million and -$239.24 million in losses. Loss per share was -$5.27.
| Revenue | 270.60M |
| Gross Profit | 244.54M |
| Operating Income | -231.83M |
| Pretax Income | -238.28M |
| Net Income | -239.24M |
| EBITDA | -223.54M |
| EBIT | -231.83M |
| Loss Per Share | -$5.27 |
Balance Sheet
The company has $386.19 million in cash and $186.37 million in debt, giving a net cash position of $199.82 million or $4.22 per share.
| Cash & Cash Equivalents | 386.19M |
| Total Debt | 186.37M |
| Net Cash | 199.82M |
| Net Cash Per Share | $4.22 |
| Equity / Book Value | 190.98M |
| Book Value Per Share | 4.03 |
| Working Capital | 365.41M |
Cash Flow
In the last 12 months, operating cash flow was -$145.08 million and capital expenditures -$582,000, giving a free cash flow of -$145.66 million.
| Operating Cash Flow | -145.08M |
| Capital Expenditures | -582,000 |
| Free Cash Flow | -145.66M |
| FCF Per Share | -$3.21 |
Margins
Gross margin is 90.37%, with operating and profit margins of -85.67% and -88.41%.
| Gross Margin | 90.37% |
| Operating Margin | -85.67% |
| Pretax Margin | -88.06% |
| Profit Margin | -88.41% |
| EBITDA Margin | -82.61% |
| EBIT Margin | -85.67% |
| FCF Margin | -53.83% |
Dividends & Yields
AXSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.73% |
| Shareholder Yield | -11.73% |
| Earnings Yield | -7.04% |
| FCF Yield | -4.29% |
Analyst Forecast
The average price target for AXSM is $119.92, which is 67.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $119.92 |
| Price Target Difference | 67.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 50.67% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AXSM has an Altman Z-Score of 3.05 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.05 |
| Piotroski F-Score | 4 |